Feb 25, 2025 08:00AM
Nov 14, 2024 07:01AM
Nov 14, 2024 07:00AM
Nov 5, 2024 07:00AM
Oct 28, 2024 08:21AM
Oct 23, 2024 08:00AM
Oct 7, 2024 08:00AM Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Sep 5, 2024 08:00AM
Aug 29, 2024 08:01AM
Aug 29, 2024 08:00AM
Aug 6, 2024 08:28AM
May 16, 2024 08:30AM
May 7, 2024 08:00AM
Apr 8, 2024 08:51AM Nuvectis Pharma's (NVCT) NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
Apr 8, 2024 08:30AM
Apr 8, 2024 08:30AM
Mar 19, 2024 08:00AM
Mar 14, 2024 09:00AM
Mar 14, 2024 09:00AM
Mar 5, 2024 08:00AM
Feb 9, 2024 08:32AM Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
Feb 9, 2024 08:00AM
Jan 3, 2024 08:00AM
Dec 18, 2023 08:00AM
Nov 8, 2023 08:00AM
Oct 24, 2023 08:00AM
Sep 25, 2023 07:30PM
Sep 21, 2023 08:00AM Nuvectis Pharma Announces Upcoming Presentations for NXP800 and NXP900
Sep 12, 2023 08:01AM
Sep 12, 2023 08:00AM
Sep 6, 2023 08:00AM
Sep 1, 2023 08:00AM
Aug 17, 2023 08:00AM
Aug 9, 2023 08:00AM
Jun 20, 2023 08:02AM Nuvectis Pharma (NVCT) to Join the Russell 2000 and Russell 3000 Indexes
Jun 20, 2023 08:00AM
May 15, 2023 08:03AM
May 15, 2023 08:00AM
May 10, 2023 08:00AM
Apr 27, 2023 10:14AM
Apr 27, 2023 08:00AM
Apr 18, 2023 08:00AM Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800's Activity in Cholangiocarcinoma PDX Models at the 2023 American Association for Cancer Research (“AACR”) Annual Meeting
Apr 18, 2023 08:00AM
Apr 10, 2023 08:01AM
Apr 10, 2023 08:00AM
Apr 10, 2023 08:00AM
Mar 7, 2023 08:00AM
Jan 4, 2023 08:03AM
Jan 4, 2023 08:00AM Nuvectis Pharma Announces Collaboration with ENGOT and GOG Foundation to Conduct the NXP800 Phase 1b Clinical Trial in ARID1A-Mutated Ovarian Carcinoma in Europe and in the United States
Jan 4, 2023 08:00AM

322,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All